Nitric oxide (NO) is synthesized from L-arginine by the Ca 2ϩ /calmodulin-sensitive endothelial NO synthase (NOS) isoform (eNOS). The present study assesses the role of Ca 2ϩ /calmodulin-dependent protein kinase II (CaMK II) in endothelium-dependent relaxation and NO synthesis. The effects of three CaMK II inhibitors were investigated in endothelium-intact aortic rings of normotensive rats. NO synthesis was assessed by a NO sensor and chemiluminescence in culture medium of cultured porcine aortic endothelial cells stimulated with the Ca 2ϩ ionophore A23187 and thapsigargin. Rat aortic endothelial NOS activity was measured by the conversion of L-[
IN ENDOTHELIAL CELLS, stimulation of muscarinic M 1 receptors by acetylcholine (ACh) results in the activation of phospholipase C-␥ 1 , followed by a transient increase in the formation of inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ] and diacylglycerol (2) . The production of Ins(1,4,5)P 3 is considered as an initial event leading to Ca 2ϩ release from intracellular stores that precedes a steady or oscillating plateau phase resulting from a more prolonged transmembranous Ca 2ϩ influx (16) . A potential target of increased intracellular free Ca -binding protein calmodulin (49, 11) when calmodulin inhibitors do not influence the relaxant response to exogenous NO (42, 37, 50) . Furthermore, the endoplasmic reticulum Ca 2ϩ -ATPase inhibitor thapsigargin, which induces an increase in [Ca 2ϩ ] i , triggers NO-dependent relaxation in vascular tissue (32) . Thus the increase in [Ca 2ϩ ] i results in the reversible formation of the Ca 2ϩ / calmodulin complex, which binds to eNOS, stimulating its activity (19) . Unstimulated endothelial cells continuously produce NO, suggesting that the intracellular Ca 2ϩ level under resting conditions is sufficient for basal NO synthesis. In endothelial cells, the main signal transduction pathway of agonist-stimulated eNOS activation depends on Ca 2ϩ /calmodulin. However, NO synthesis can be, at least in part, regulated by serine/threonine kinases, including cAMP-dependent protein kinase (9, 7) , protein kinase C (36, 26) , and protein kinase B/Akt (20, 14) . Although eNOS contains consensus sequences for phosphorylation by serine/ threonine kinases, its regulation by Ca 2ϩ -dependent and/or Ca 2ϩ -independent phosphorylation remains to be specified. Ca 2ϩ /calmodulin-dependent protein kinase II (CaMK II) is a ubiquitous Ca 2ϩ /calmodulindependent enzyme involved in various Ca 2ϩ -mediated mechanisms. Its relationship with neuronal NOS (nNOS) has been previously established by Nakane et al. (35) . Although Deli et al. (13) showed that CaMK II was expressed in endothelial cells, the link between CaMK II and NO synthesis in the endothelium re-mains largely unknown. We hypothesized that CaMK II might modulate Ca 2ϩ -mobilizing agent-dependent eNOS activity. The role of CaMK II in rat aorta endothelium-dependent relaxation was investigated by pretreatment with CaMK II inhibitors. Furthermore, we studied the interaction between Ca 2ϩ -induced NO production and CaMK II-dependent phosphorylation by measuring NO release and eNOS activity in a cultured porcine aortic endothelial cell (PAEC) line and rat aortic endothelial cells pretreated with CaMK II inhibitors.
MATERIALS AND METHODS
Drugs. Reagents were from Sigma and RBI, distributed by Sigma (Saint-Quentin Fallavier, France), unless otherwise stated. Polypeptide 281-302 (P281-302) bound calmodulin and was a potent inhibitor (IC 50 ϭ 80 nM) of exogenous substrate phosphorylation (12) . KN-93 was an inhibitor of CaMK II activation (K i ϭ 0.37 M) (45) . Its related compound, KN-92, does not show any CaMK II inhibitory activity. Lavendustin C (Calbiochem; Meudon, France) is a potent inhibitor of CaMK II (IC 50 ϭ 200 nM). Lavendustin C has noncompetitive inhibitory action on the tyrosine kinase ATP binding site and uncompetitive inhibitory action on the peptide binding site (3). P281-302 was dissolved in desoxygenated bidistilled water. KN-93, KN-92, and lavendustin C were dissolved in DMSO to prepare a stock solution of 0.01 M. Phenylephrine hydrochloride (␣ 1-adrenoreceptor agonist), acetylcholine chloride (muscarinic agonist), Ca 2ϩ ionophore A23187, sodium nitroprusside (NO donor), and N -nitro-Larginine methyl ester hydrochloride (L-NAME; analog of arginine and competitive isozyme-nonselective NOS inhibitor) were made up in bidistilled deionized water. Thapsigargin (Calbiochem) was dissolved in DMSO. Each was made fresh daily and protected from light. All other drugs were dissolved in bidistilled deionized water except indomethacin, which was dissolved in ethanol. Further dilutions were made in Krebs solution for in vitro experiments. The drug solutions were prepared each day from dry powder.
Tissue preparation and tension measurement. All animal procedures were applied in accordance with the European Directive for Animal Experiments 86/609 (Centre National de la Recherche Scientifique; Paris, France). At the time of experimentation, adult male Sprague-Dawley rats (251-275 g, Charles River; Saint-Aubin Les Elbeufs, France) were anesthetized with thiopental sodium (Nesdonal; 80 mg/kg ip) and heparinized (100 IU ic). A thoracotomy was performed, and the aorta was excised en bloc in cold Krebs balanced salt solution [composed of (in mM) 118 NaCl, 5.9 KCl, 1.2 MgSO 4 ⅐ 7H2O, 1.2 NaH2PO4 ⅐ 2H2O, 2.5 CaCl2 ⅐ 2H2O, 25.5 NaHCO3, and 5.6 D-glucose] containing 1 mM indomethacin. The thoracic aorta of internal diameter 2.5 Ϯ 0.2 mm was isolated clean of adherent fat and connective tissue and cut into rings of 3.0 mm in length. The vessel was gently handled to avoid stretching and endothelial damage. Two L-shaped stainless steel wires were inserted into the arterial lumen, and the rings were suspended in a 20-ml tissue bath. One stainless steel holder was attached to the chamber, and the other holder was attached to an isometric force-displacement transducer (Emka Technologie; Paris, France). The temperature of the organ chambers was kept constant at 37°C in Krebs buffer solution gassed with 95% O 2-5% CO2 (Air Liquide Santé; Paris, France). The rings were set at an initial resting tension of 1.5 g (the resting tension previously determined to be the optimal tension for length development in response to 60 mM KCl) and allowed to equilibrate for 60 min, the rings being repeatedly washed every 15 min. Verification of endothelium integrity was performed by testing the vascular relaxation produced in phenylephrine (0.1 M)-precontracted rings by the endothelium-dependent vasodilator ACh (0.1 M). In experiments with endothelium-denuded rat aortic rings, the endothelial cell layer was removed by rubbing the luminal surface of the vessel with a cotton swab. After equilibration, the vascular rings were submaximally precontracted with phenylephrine (1 M), and a stepwise pharmacological sequence was initiated.
Characterization of the pharmacological responsiveness of aortic rings. At the plateau phase, concentration-relaxation curves to ACh (0.001-10 M), Ca 2ϩ ionophore A23187 (0.01-100 M), and thapsigargin (0.001-10 M) were constructed by increasing the concentration in the organ chamber in cumulative increments after a steady-state response had been reached with each increment on precontracted rings. After the highest concentration of ACh, the rings were totally relaxed by sodium nitroprusside (10 M). In preincubation experiments, CaMK II inhibitors were added to the bath at the plateau phase, and relaxation was proceeded after equilibration with the tissue for 15 min. Two concentrations of P281-302, KN-93, and lavendustin C were administrated, corresponding to 10 Ϫ6 and 10 Ϫ7 M in a 20-ml organ chamber for P281-302 and lavendustin C and to 10 Ϫ5 and 10 Ϫ6 M for KN-93. KN-93 and lavendustin C were also added at 10 Ϫ5 -10 Ϫ3 M to assess their effect at high concentration in endothelium-denuded vascular rings. Controls were determined by the addition of vehicle (0.01% DMSO) or KN-92 (1 M).
Histology. Endothelium integrity was assessed by postpharmacological challenge histology analysis. Tissues were harvested, fixed in 10% neutral buffered formaldehyde, embedded in paraffin, and sectioned. Histological sections (5 m thick) were stained with hematoxylin and eosin (Sigma) and examined.
PAEC culture. All the reagents used for cell culture were from GIBCO-BRL (Cergy-Pontoise, France) if not otherwise specified. The PAEC line established by Malassagne et al. (27) was a gift from Dr. Bernard Weill (Laboratoire d'Immunologie Biologique, Hôpital Cochin; Paris, France). PAECs were cultured in 25-cm 2 Primaria dishes (Polylabo; Paris, France) in RPMI 1640 medium-glutamax-1 supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 50 g/ml amphotericin B, and 10% fetal bovine serum. The cultures were incubated at 37°C in a humid atmosphere with 5% CO2. When cells reached confluence, they were detached by incubation with 0.05% trypsin-EDTA in RPMI 1640 medium-glutamax-1 for 3 min at 37°C, centrifuged at 300 g for 10 min, suspended in fresh complete medium, and further cultured under the same conditions. Cells were characterized as endothelial cells by their morphology, their ability to take up acetylated low-density lipoproteins (34), the detection of von Willebrand factor (41) , and the expression of E-selectin (27) .
Cell stimulation. At least four sets of transfected cells (passages 29 and 30) were tested. The cells were subcultured in 24-well flat-bottom culture plates (10 5 cells/well) during 24 h to reach confluence. The culture medium was removed, and the cells were washed once and equilibrated in isotonic phosphate buffer (pH 7.4) containing (in mM) 8 Na2HPO4, 1.5 KH2PO4, 137 NaCl, 2.7 KCl, 0.9 CaCl2,1 MgCl2, and 1 indomethacin oxygenated with 95% O2-5% CO2 (Air Liquide Santé). For real-time NO measurements, the sensor probe was inserted vertically into a well with confluent cells, the sensor membrane was positioned 50 M above the monolayer by using a manual micromanipulator, and the well was sealed. To investigate the response to the agonists, the cells were stimulated with either A23187 (5 ϫ 10 Ϫ8 -10 Ϫ5 M) or thapsigargin (5 ϫ 10 Ϫ9 -10 Ϫ5 M). The effect of CaMK II was evaluated on the concentration-response curve for A23187 or thapsigargin of cells previously incubated with KN-93 during 30 min. For nitrate and nitrite (NO x) measurements, the cells were incubated with KN-93 (1 M) or KN-92 (1 M). After the cells were incubated for 30 min, they were stimulated by the Ca 2ϩ ionophore A23187 (0.1, 1, and 10 M) or thapsigargin (0.1, 1, and 10 M). The samples of effluent were then withdrawn from the culture well and immediately centrifuged at 300 g and 0°C for 10 min. The NO x concentration was determined in the supernatant by chemiluminescence.
Rat aortic endothelial cell culture. The isolation of primary rat aortic cells was achieved according to the method of McGuire et al. (29) . Cells were placed on a substrate including laminin and cultured in RPMI 1640 medium supplemented with 20% fetal calf serum. They were characterized by the detection of von Willebrand factor (41) and their ability to uptake acetylated low-density lipoproteins (34) .
Cell stimulation. Cells were subcultured in six-well flatbottom culture plates (4 ϫ 10 5 cells/well) and incubated with KN-93 (1 M) before stimulation with bradykinin (0.1 mM). The cells were detached by incubation with 0.05% trypsin-EDTA, centrifuged at 300 g for 10 min, and suspended in Tris ⅐ HCl (50 mM, pH 7.4) with EGTA (0.1 mM), EDTA (0.1 mM), leupeptin (1 M), aprotinin (1 M), and PMSF (1 M) to measure eNOS activity.
NOx measurement. The NOx content in the culture medium was determined by measuring NO based on a gas phase chemiluminescent reaction between NO and ozone with a NO analyzer (model 280, Sievers Intruments; Boulder, CO) (31). Nitrite and nitrate were reduced by vanadium and hydrochloric acid at 90°C. NO release in the headspace was purged from the solution by an inert gas for subsequent detection by chemiluminescence. Raw data were recorded with a NO analysis liquid program (Sievers Intruments), and the peaks were integrated. The sample concentrations were computed by using a previously determined calibration curve.
Electrochemical detection of NO. S-nitroso-N-acetyl penicillamine (SNAP), CuCl, EDTA, and NaOH were obtained from Sigma-Aldrich and Fluka. All the solutions were dissolved in desoxygenated bidistilled water. Amperometric measurements of NO released were quantified with a Clarktype electrode (2 mm platinum disk NO sensor, Iso-NOP, World Precision Instruments; Stevenage, UK) connected to a Iso Mark II NO meter (World Precision Instruments). The newly developed electrode has a high selectivity for NO and a detection sensitivity of 1 nM. The principles of measurement have previously been described (44) . NO diffusing through the gas-permeable membrane is oxidized at the working platinum electrode. The resulting redox current is proportional to the concentration of NO gas in the aqueous solution. The output current was recorded with the constant laboratory temperature kept constant. Calibration of the electrode was performed daily according to the procedure described by Zhang et al. (52) . The NO sensor was immersed in saturated CuCl solution. After stabilization, a known volume of the SNAP solution (final concentration of 10, 20, 50, 100, and 200 nM) was then added, and the response was monitored. Measurements of NO were performed under constant stirring in glass vials sealed with a septum. Linear calibration curves were obtained from the resulting calibration plot.
eNOS activity. NOS activity was measured by the conversion of L (25) . After the migration, the proteins were transferred on nitrocellulose membranes in semidry transfer buffer [25 mM Tris (pH 7.5), 200 mM glycine, and 20% methanol]. The blots were blocked in 1% bovine serum albumin, 25 mM Tris (pH 7.5), 150 mM NaCl, and 0.05% Tween 20 and incubated with CaMK II antibodies (Transduction Laboratories; Lexington, UK) for 30 min at 37°C. After being washed, the membranes were incubated with horseradish peroxidase-conjugated anti-mouse IgG and developed according to the enhanced chemiluminescence immunodetection procedure (Amersham Pharmacia Biotech; Orsay, France).
Data analysis. All responses to phenylephrine were expressed as force (in g). Responses to vasodilator agents were expressed as a percentage of maximal relaxation. In the endothelium-intact vessels, the effects of CaMK II inhibitors were measured on two rings for each aorta and the values were averaged. For all experiments, n is the number of rat aorta studies. Data are expressed as means Ϯ SE of n number of experiments. Results were analyzed using twoway ANOVA with repeated measures to compare the effects of inhibitors versus control with increasing concentrations of ACh. When the F-value for an effect was globally significant, comparisons were made using the Mann-Whitney U-test. The NO x concentration was normalized for cell number, and the results were expressed as the content of NO release (in nM) per 10 5 cells. The cell counts were obtained manually using a hemocytometer (Neubauer type), with viabilities determined by trypan blue dye exclusion. The cells were counted after experimentation. NOx measurements were realized twice and averaged, and n corresponds to the number of sets analyzed. Statistical evaluation of the difference between pretreated PAECs and the control was assessed with Student's two-tailed t-test. All statistical tests were considered significant for an ␣-level below 0.05. Treatment of aortic rings with KN-93 (1 and 10 M) decreased the ACh-induced relaxation by 23 Ϯ 3% and 29 Ϯ 3% for 1 and 10 M, respectively, at an ACh concentration of 10 Ϫ6 M and by 20 Ϯ 2% and 28 Ϯ 6% for 1 and 10 M, respectively, at an ACh concentration of 10 Ϫ5 M (P Ͻ 0.05, n ϭ 5). Its inactive analog, KN-92 (1 M), did not affect the ACh-induced relaxation (Fig. 2) .
RESULTS

Effects of CaMK II inhibitors on endothelium-dependent relaxation to
Lavendustin C (0.1 and 1 M) elicited a concentration-dependent reduction of ACh-induced relaxation of aortic rings precontracted with phenylephrine by 17 Ϯ 9% and 28 Ϯ 3% for 0.1 and 1 M, respectively, at an ACh concentration of 10 Ϫ6 M and by 14 Ϯ 7% and 14 Ϯ 5% for 0.1 and 1 M, respectively, at an ACh concentration of 10 Ϫ5 M (P Ͻ 0.05, n ϭ 5; Fig. 3 ). Vehicle (0.01% DMSO) had no effect on both phenylephrine-induced contraction and ACh-induced relaxation. 
Effects of CaMK II inhibitors on endothelium-dependent relaxation to A23187 and thapsigargin. In precontracted endothelium-intact aortic rings, A23187 (10
8% at a thapsigargin concentration of 10
Ϫ6 M and by 13 Ϯ 5% at a thapsigargin concentration of 10 Ϫ5 M (P Ͻ 0.05, n ϭ 6). Its inactive analog, KN-92 (1 M), did not affect the thapsigargin-induced relaxation (Fig. 5) .
Effects of CaMK II inhibitors on exogenous NO-induced relaxation. Sodium nitroprusside (10 M) totally relaxed the aortic ring (98 Ϯ 2%). Neither CaMK II inhibitors nor the inactive analog KN-92 at all concentrations have inhibitory action on sodium nitroprusside (10 M) relaxation (data not shown). None of the three CaMK II inhibitors evoked spontaneously relaxation in endothelium-intact or -denuded vascular rings.
Effect of CaMK II inhibitors on endothelium-denuded and -intact aortic ring contraction.
In endothelium-denuded aortic rings, the three CaMK II inhibitors did not have an inhibitory action on phenylephrine (1 M) contraction. In endothelium-intact aortic rings, both P281-302 (1 M) and KN-93 (10 M) did not alter phenylephrine (an ␣ 1 -adrenoreceptor agonist) contraction. However, lavendustin C at a concentration of 10 M induced an additional contraction of endotheliumintact aortic rings precontracted with phenylephrine by 18 Ϯ 7% (P Ͻ 0.05, n ϭ 5). The lavendustin Cinduced increase in vascular tone was inhibited by L-NAME (10 M).
Immunoblot characterization of CaMK II-␣. After SDS-PAGE and semidry transfer, membrane extracts of PAECs were revealed with anti-CaMK II isotype IgG 1 . IgG 1 bound to 52-kDa antigens. The same band was revealed on the control (rat brain lysate; Fig. 6) .
Effect of the CaMK II inhibitor KN-93 on NO production. In cultured endothelial cells, A23187 (5 ϫ 10
Ϫ8 -10 Ϫ5 M) and thapsigargin (5 ϫ 10 Ϫ9 -10 Ϫ5 M) induced NO release (EC 50 ϭ 9.12 ϫ 10 Ϫ7 and 7.24 ϫ 10 Ϫ7 M, respectively). Preincubation with L-NAME (10 M) inhibited agonist-induced NO release. KN-93 (1 M) shifted to the right the concentration-response curve of A23187-and thapsigargin-induced NO release (EC 50 ϭ 1.26 ϫ 10 Ϫ6 and 9.77 ϫ 10 Ϫ7 M, respectively; Fig. 7 ).
Decreased NO x concentration by KN-93 on cultured endothelial cells stimulated by A23187 or thapsigargin.
Stimulation of endothelial cells with the Ca 2ϩ ionophore A23187 (1 and 10 M) increased the NO x concentration in PAEC culture medium by 1,477 Ϯ 51 and 2,075 Ϯ 111 nM/10 5 cells, respectively. L-NAME (10 M) inhibited the NO x production. The background NO x concentration from the isotonic phosphate buffer was 114 Ϯ 20 nM/10 5 cells. KN-93 (1 M) reduced the NO x concentration in culture medium of PAECs stimulated with A23187 (1 and 10 M) by 26 Ϯ 5% and 10 Ϯ 4%, respectively (P Ͻ 0.05, n ϭ 4; Fig. 7A ). CaMK II inhibitor reduced the NO x concentration in the culture medium of PAECs stimulated with thapsigargin (1 and 10 M) by 22 Ϯ 4% and 17 Ϯ 5%, respectively (P Ͻ 0.05, n ϭ 4; Fig. 7B ). . Note that eNOS activity in rat aortic endothelial cells was totally inhibited by L-NAME (Fig. 8) .
DISCUSSION
Our results provide evidence that three different CaMK II inhibitors decreased endothelium-dependent relaxation elicited by ACh in normotensive rats. None of the CaMK II inhibitors inhibited relaxation induced by NO donors. KN-93 inhibited both receptor-independent and -dependent agonist-induced relaxation. The effects of CaMK II inhibitors were confirmed in both the PAEC line and rat aortic endothelial primary cultured cells. In the former, KN-93 significantly decreased the NO release in response to both the Ca 2ϩ ionophore A23187 and thapsigargin. In the latter, KN-93 markedly reduced bradykinin-stimulated eNOS activity. Our results suggest that NO synthesis is dependent on CaMK II. The involvement of CaMK II in porcine endothelial NO production and rat NO-dependent relaxation characterized by the response to P281-302, KN-93, and lavendustin C on endothelium-dependent relaxation may be due to 1) an interference with ACh-induced Ca 2ϩ release, 2) a direct effect on eNOS and/or calmodulin phosphorylation, and 3) an inhibition of NO-independent vascular smooth muscle relaxation.
To avoid bias due to nonspecific inhibitory effects of the compounds, our experiments were repeated with three structurally different CaMK II inhibitors. internal stores. In concert, our data support the hypothesis that CaMK II is involved downstream of the mobilization of intracellular Ca 2ϩ stores directly on eNOS activation.
As with other NOS isoforms, eNOS might represent a direct protein substrate for CaMK II (43) . However, Bredt et al. (7) reported no effect on soluble nNOS, whereas Nakane et al. (35) showed that CaMK IIinduced phosphorylation of nNOS decreased its activity. Alternatively, Toda et al. (47) have shown that, in the cerebral artery, NO-mediated relaxation was attenuated by an inhibitor of CaMK II. This different behavior may be explained by the particular localization of eNOS in endothelial cells, where it is initially targeted to the membrane fraction (38) and subsequently translocated from the membrane to the soluble fraction after stimulation of the cells (30) . This particular property of eNOS is partly due to the presence of NH 2 -terminal myristoylation and palmitoylation (10, 39) . However, these posttranslational modifications are not sufficient for membrane localization, and phosphorylation of the enzyme is an alternative mechanism for the reversible association of the enzyme with membrane phospholipids (28) . Alternatively, in cultured endothelial cells, agonist-induced eNOS phosphorylation increases its sensitivity to activation by Ca 2ϩ (17) . Thus pretreatment of endothelial cells with CaMK II inhibitors might either inhibit the translocation of eNOS or enhance the desensitization to Ca 2ϩ . Our results showing the decrease of eNOS activity in parallel of the reduction of NO-dependent relaxation suggest that CaMK II directly phosphorylates eNOS protein. This hypothesis was recently confirmed by Fleming et al. (18) , who demonstrated that porcine eNOS activity depends on serine (Ser 1177 ) eNOS phosphorylation by CaMK II. Their biochemical approach, together with our results, demonstrate the effect of CaMK II inhibitors on PAEC NO production and rat aorta endothelium-dependent relaxation after stimulation by Ca 2ϩ -mobilizing agents.
Our results with sodium nitroprusside suggest that CaMK II did not affect soluble guanylyl cyclase activity. These findings are consistent with those of Toda et al. (47) , who showed that the response to exogenous NO was unaffected by CaMK II inhibitors, whereas the agonist-dependent NO-induced increase in cGMP concentration was reduced. Thus ACh-induced relaxation was attenuated by CaMK II inhibitors, indicating their roles in NO synthesis. Furthermore, CaMK II inhibitors did not spontaneously relax endothelium-denuded rat aortic rings, suggesting that an endothelium-insensitive effect may be ruled out.
CaMK II has been implicated in the regulation of tonic vascular smooth muscle contractility mediated by myosin light chain phosphorylation (1, 46, 40) . However, the CaMK II inhibitor KN-93 did not impair the contraction in response to the ␣ 1 -adrenoreceptor agonist phenylephrine (24) . Our results with endotheliumdenuded aortic rings confirm that vascular smooth muscle was insensitive to KN-93. However, a high concentration of lavendustin C slightly increased endothelium-intact contraction, suggesting that lavendustin C can increase vasoconstrictor tone by inhibiting basal NO activity. This hypothesis was confirmed by the absence of the lavendustin C contractile effect in the presence of L-NAME.
In conclusion, P281-302, KN-93, and lavendustin C, three structurally different CaMK II inhibitors, decreased the endothelium-dependent relaxation of isolated vessels and NO production by endothelial cells. These results suggest that, in addition to protein kinases A, B, and C, CaMK II was involved in NO synthesis. The agonist-induced [Ca 2ϩ ] i increase leads to Ca 2ϩ /calmodulin-mediated eNOS activation but may also potentiate the NO synthesis by CaMK IIdependent phosphorylation of eNOS. Thus CaMK II modulates, at least in part, the activity and/or the intracellular localization of eNOS and may add another level of regulation in endothelium-dependent relaxation, which is of pharmacological interest in cardiovascular therapy.
